All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| HZNP / Horizon Therapeutics Plc
|
|
|
|
|
|
|
|
| MIRM / Mirum Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| CLDX / Celldex Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ALGN / Align Technology, Inc.
|
|
|
|
|
|
|
|
| ATHA / Athira Pharma, Inc.
|
|
|
|
|
|
|
|
| OTIC / Otonomy Inc
|
|
|
|
|
|
|
|
| ARK ETF TR
/ Genomic Rev ETF Put (00214Q952) |
|
|
|
|
|
|
|
| CYT / Cyteir Therapeutics, Inc.
|
|
|
|
|
|
|
|
| OEF / iShares Trust - iShares S&P 100 ETF Put
|
|
|
|
|
|
|
|
| AMGN / Amgen Inc.
|
|
|
|
|
|
|
|
| APTO / Aptose Biosciences Inc.
|
|
|
|
|
|
|
|
| ALGS / Aligos Therapeutics, Inc.
|
|
|
|
|
|
|
|
| CCXI / ChemoCentryx Inc Call
|
|
|
|
|
|
|
|
| PBYI / Puma Biotechnology, Inc.
|
|
|
|
|
|
|
|
| DXCM / DexCom, Inc.
|
|
|
|
|
|
|
|
| QURE / uniQure N.V.
|
|
|
|
|
|
|
|
| PTCT / PTC Therapeutics, Inc.
|
|
|
|
|
|
|
|
| VERA / Vera Therapeutics, Inc.
|
|
|
|
|
|
|
|
| INZY / Inozyme Pharma, Inc.
|
|
|
|
|
|
|
|
| AZN / AstraZeneca PLC - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| XLB / The Select Sector SPDR Trust - The Materials Select Sector SPDR Fund Put
|
|
|
|
|
|
|
|
| SNDX / Syndax Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| MRUS / Merus N.V.
|
|
|
|
|
|
|
|
| PODD / Insulet Corporation
|
|
|
|
|
|
|
|
| AVTE / Aerovate Therapeutics, Inc.
|
|
|
|
|
|
|
|
| TCRR / Tcr2 Therapeutics Inc
|
|
|
|
|
|
|
|
| OBSV / ObsEva SA.
|
|
|
|
|
|
|
|
| KURA / Kura Oncology, Inc.
|
|
|
|
|
|
|
|
| FGEN / FibroGen, Inc. Put
|
|
|
|
|
|
|
|
| HRTX / Heron Therapeutics, Inc. Call
|
|
|
|
|
|
|
|
| EXEL / Exelixis, Inc.
|
|
|
|
|
|
|
|
| ARNA / Arena Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| PDSB / PDS Biotechnology Corporation
|
|
|
|
|
|
|
|
| FATE / Fate Therapeutics, Inc.
|
|
|
|
|
|
|
|
| AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| NCNA / NuCana plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| AKUS / Akouos Inc
|
|
|
|
|
|
|
|
| TCRR / Tcr2 Therapeutics Inc Put
|
|
|
|
|
|
|
|
| ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| 14161H108 / Cardtronics PLC
|
|
|
|
|
|
|
|
| CMPI / Checkmate Pharmaceuticals Inc
|
|
|
|
|
|
|
|
| CCXI / ChemoCentryx Inc Put
|
|
|
|
|
|
|
|
| CALA / Calithera Biosciences, Inc.
|
|
|
|
|
|
|
|
| NBIX / Neurocrine Biosciences, Inc.
|
|
|
|
|
|
|
|
| XLRN / Acceleron Pharma Inc
|
|
|
|
|
|
|
|
| AGIO / Agios Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| CCXI / ChemoCentryx Inc
|
|
|
|
|
|
|
|
| RETA / Reata Pharmaceuticals Inc - Class A
|
|
|
|
|
|
|
|
| ITCI / Intra-Cellular Therapies, Inc.
|
|
|
|
|
|
|
|
| VRTX / Vertex Pharmaceuticals Incorporated
|
|
|
|
|
|
|
|
| SRRA / Sierra Oncology Inc
|
|
|
|
|
|
|
|
| JNCE / Jounce Therapeutics Inc
|
|
|
|
|
|
|
|
| HRTX / Heron Therapeutics, Inc.
|
|
|
|
|
|
|
|
| CHRS / Coherus Oncology, Inc.
|
|
|
|
|
|
|
|
| JAZZ / Jazz Pharmaceuticals plc
|
|
|
|
|
|
|
|
| PTGX / Protagonist Therapeutics, Inc.
|
|
|
|
|
|
|
|
| BOLT / Bolt Biotherapeutics, Inc.
|
|
|
|
|
|
|
|
| CYTK / Cytokinetics, Incorporated
|
|
|
|
|
|
|
|
| RGNX / REGENXBIO Inc.
|
|
|
|
|
|
|
|
| MRTX / Mirati Therapeutics, Inc.
|
|
|
|
|
|
|
|
| BCRX / BioCryst Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| MGNX / MacroGenics, Inc.
|
|
|
|
|
|
|
|
| BIIB / Biogen Inc.
|
|
|
|
|
|
|
|
| LLY / Eli Lilly and Company
|
|
|
|
|
|
|
|
| CTIC / CTI BioPharma Corp
|
|
|
|
|
|
|
|
| UTHR / United Therapeutics Corporation
|
|
|
|
|
|
|
|
| NXTC / NextCure, Inc.
|
|
|
|
|
|
|
|
| YMAB / Y-mAbs Therapeutics, Inc.
|
|
|
|
|
|
|
|
| KRTX / Karuna Therapeutics, Inc.
|
|
|
|
|
|
|
|
| GRTX / Galera Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ACAD / ACADIA Pharmaceuticals Inc. Call
|
|
|
|
|
|
|
|
| NTRA / Natera, Inc.
|
|
|
|
|
|
|
|
| SYBX / Synlogic, Inc.
|
|
|
|
|
|
|
|
| REPL / Replimune Group, Inc.
|
|
|
|
|
|
|
|
| IMTX / Immatics N.V.
|
|
|
|
|
|
|
|
| SRPT / Sarepta Therapeutics, Inc.
|
|
|
|
|
|
|
|
| AGEN / Agenus Inc.
|
|
|
|
|
|
|
|
| GILD / Gilead Sciences, Inc. Call
|
|
|
|
|
|
|
|
| INSM / Insmed Incorporated
|
|
|
|
|
|
|
|
| SVRA / Savara Inc.
|
|
|
|
|
|
|
|
| MRNS / Marinus Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
